Defining a common region of deletion at 13q21 in human cancers
- PMID: 11433524
- DOI: 10.1002/gcc.1152
Defining a common region of deletion at 13q21 in human cancers
Abstract
Previous molecular genetic analyses identified a region of deletion at 13q21 in a variety of human cancers, suggesting the existence of a tumor suppressor gene(s) at this locus. In our earlier study on prostate cancer, the region of deletion was confined to a 3.1 cM interval between D13S152 and D13S162. At present, however, no known gene located in this interval has been firmly implicated in cancer, and the region remains too large for gene identification. To fine-map the area of interest, we established a contig of bacterial artificial chromosome (BAC) clones, narrowed the region of deletion by loss of heterozygosity (LOH) and homozygosity-mapping-of-deletion (HOMOD) analyses in different types of cancers, and tested a candidate gene from the region for mutation and alteration of expression in prostate cancers. The contig consisted of 75 overlapping BAC clones. In addition to the generation of 47 new sequence-tagged-site (STS) markers from the ends of BAC inserts, 76 known STS and expressed sequence tag markers were mapped to the contig (25 kb per marker on average). The minimal region of deletion was further defined to be about 700 kb between markers D13S791 and D13S166 by LOH analysis of 42 cases of prostate cancer, and by HOMOD analysis of eight prostate cancer cell lines/xenografts and 49 cell lines from cancers of the breast, ovary, endometrium, and cervix, using 18 microsatellite markers encompassing the deletion region. A gene that is homologous to the WT1 tumor suppressor gene, AP-2rep (KLF12), was mapped in this region and was analyzed for its expression and genetic mutation. In addition to low levels of expression in both normal and neoplastic cells of the prostate, this gene did not have any mutations in a group of aggressive prostate cancers and cell lines/xenografts, as assessed by the methods of polymerase chain reaction-single strand conformational polymorphism analysis and direct sequencing. These studies suggest that a 700 kb interval at 13q21 harbors a tumor suppressor gene(s) that seems to be involved in multiple types of cancer, and that the AP-2rep gene is unlikely to be an important tumor suppressor gene in prostate cancer. The BAC contig and high-resolution physical map of the defined region of deletion should facilitate the cloning of a tumor suppressor gene(s) at 13q21.
Copyright 2001 Wiley-Liss, Inc.
Similar articles
-
An 800-kb region of deletion at 13q14 in human prostate and other carcinomas.Genomics. 2001 Oct;77(3):135-44. doi: 10.1006/geno.2001.6631. Genomics. 2001. PMID: 11597138
-
Deletion at 13q21 is associated with aggressive prostate cancers.Cancer Res. 2000 Jul 15;60(14):3880-3. Cancer Res. 2000. PMID: 10919663
-
A 700-kb physical and transcription map of the cervical cancer tumor suppressor gene locus on chromosome 11q13.Genomics. 2005 Jun;85(6):704-14. doi: 10.1016/j.ygeno.2005.02.014. Epub 2005 Apr 9. Genomics. 2005. PMID: 15885497
-
[Chromosome arm 17p13.3: could HIC1 be the one ?].Med Sci (Paris). 2006 Jan;22(1):54-61. doi: 10.1051/medsci/200622154. Med Sci (Paris). 2006. PMID: 16386221 Review. French.
-
Involvement of the multiple tumor suppressor genes and 12-lipoxygenase in human prostate cancer. Therapeutic implications.Adv Exp Med Biol. 1997;407:41-53. doi: 10.1007/978-1-4899-1813-0_7. Adv Exp Med Biol. 1997. PMID: 9321930 Review.
Cited by
-
The DACH1 gene is frequently deleted in prostate cancer, restrains prostatic intraepithelial neoplasia, decreases DNA damage repair, and predicts therapy responses.Oncogene. 2023 Jun;42(22):1857-1873. doi: 10.1038/s41388-023-02668-9. Epub 2023 Apr 24. Oncogene. 2023. PMID: 37095257 Free PMC article.
-
The DACH1 gene is frequently deleted in prostate cancer, restrains prostatic intraepithelial neoplasia, decreases DNA damage repair, and predicts therapy responses.Res Sq [Preprint]. 2023 Jan 10:rs.3.rs-2423179. doi: 10.21203/rs.3.rs-2423179/v1. Res Sq. 2023. Update in: Oncogene. 2023 Jun;42(22):1857-1873. doi: 10.1038/s41388-023-02668-9. PMID: 36712010 Free PMC article. Updated. Preprint.
-
Genetic polymorphism of rs9564966 G > A on 13q22.1 predicts poor survival for Chinese patients with gastric cancer.Cancer Med. 2019 Jan;8(1):428-436. doi: 10.1002/cam4.1693. Epub 2018 Dec 8. Cancer Med. 2019. PMID: 30537204 Free PMC article.
-
KLF5 promotes the tumorigenesis and metastatic potential of thyroid cancer cells through the NF-κB signaling pathway.Oncol Rep. 2018 Nov;40(5):2608-2618. doi: 10.3892/or.2018.6687. Epub 2018 Sep 6. Oncol Rep. 2018. PMID: 30226614 Free PMC article.
-
Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.Nat Commun. 2016 Apr 27;7:11375. doi: 10.1038/ncomms11375. Nat Commun. 2016. PMID: 27117709 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases